Liquid-based cytology for risk-adapted cervical screening

Authors

  • Reinhard Bollmann Institute of Pathology Bonn-Duisdorf, Bonn, Germany

DOI:

https://doi.org/10.18370/2309-4117.2015.21.95-101

Keywords:

liquid cytology, Pap smear, cell block, DNA cytometry, molecular PAP tests

Abstract

Currently, there are three liquid based cytology (LBC) systems used in Germany: the ThinPrep®, the SurePath® and the PapSpin® method. There are only very few differences between the cytomorphology of LBC and conventional Pap smears. The main difference is the clear background provided by LBC, which makes it easier to identify and interpret abnormal cells. So far, evidence suggests that liquid-based cytological methods offer the following advantages compared to traditional smear techniques: a) a reduction in the proportion of inadequate specimens, b) an improvement in sensitivity, and c) a possible reduction in specimen interpretation times.

In the USA, 98% of the Pap tests are nowadays liquid-based.

References

  1. Baak, J., Kruse, A., Janssen, E., van Diermen, B. “Prediktive testing of early CIN behaviour by molecular biomarkers.” Cell Oncol, 27(2005): 277–280.
  2. Bayer-Pietsch, E., Flenker, H. “Gynakologische Zytologie mit der PapSpin-Technik. Eine Alternative zum konventionellen Abstrich nach Papanicolaou?” Frauenarzt, 45(2004): 1057–1062.
  3. Bentz, J.S., Rowe, L.R., Gopez, E.V., Marshall, C.J. “The unsatisfactory ThinPrep Pap Test: missed opportunity for disease detection?” Am J Clin Pathol, 117(2002): 457–463.
  4. Bicotti, C.V., Dawson, A.E., Dziura, B., Galup, L., Darragh, T., Rahemtulla, A., Wills-Frank, L. “Assisted primary screening using the automated ThinPrep Imaging System.” Am J Clin Pathol, 123(2005): 281–287.
  5. Bollmann, M., Bankfalvi, A.,Trosic, A., Speich, N., Schmitt, C., Bollmann, R. “Can we detect cervical human papillomavirus (HPV) infection by cytomorphology alone? Diagnostic value of non-classic cytological signs of HPV effect in minimally abnormal Pap test.” Cytopathology, 16(2005): 13–21.
  6. Bollmann, R., Bollmann, M., Henson, D.E., Bodo, M. “DNA Cytometry confirms the Utility of the Bethesda System for the Classification of Papanicolaou Smears.” Cancer Cytopathol, 93(3) (2001): 222–228.
  7. Bollmann, R., Jordan, B. “Technische Voraussetzungen einer validierten Flussigkeitszytologie. Reicht die einfache Zytozentrifugation?” Frauenarzt, 46(2005): 402–405.
  8. Bollmann, R., Torka, R., Schmitz, J., Bollmann, M., Mehes, G. “Determination of Ploidy and Steroid Receptor Status in Breast Cancer by Laser Scanning Cytometry.” Cytometry, 50(2002): 211–215.
  9. Bollmann, R., Varnai, A.D., Bankfalvi, A., Bollmann, M. “Risikoadaptierte multimodale gynakozytologische Krebsvorsorge – PapTest der Zukunft?” Pathologe, (5)2007: 334–338.
  10. Bollmann, M., Varnai, A.D., Griefingholt, H., Bankfalvi, A., Callenberg, H., Speich, N., Schmitt, C., Bollmann, R. “Predicting treatment outcome in cervical diseases using liquidbased cytology, dynamic HPV genotyping and DNA cytometry.” Anticancer Res, 26(2B) (2006): 1439–1446.
  11. Bollmann, R., Bankfalvi, A., Griefingholt, H., Trosic, A., Speich, N., Schmitt, C., Bollmann, M. “Validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: Results from 31031 women from the Bonnregion in West Germany.” Oncol Rep, 13(2005): 915–922.
  12. Cervical Screening, Wales. Statistical Report 2006. Cardiff: Cervical Screening Wales KC 2006; 53/61/65.
  13. Davey, E., Barratt, A., Irwig, L., Chan, S.F., Macaskill, P., Mannes, P., Saville, A.M. “Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: A systematic review.” Lancet, 367(2006): 122–132.
  14. Davey, E., d’Assuncao, J., Irwig, L., Macaskill, P., Chan, S.F., Richards, A., Farnsworth, A. “The Accuracy of Cervical Cytology: A comparison between the ThinPrep Imaging System and conventional Methods.” BMJ, 31 (2007): 335. Epub Jun 29, 2007.
  15. Davey, E., Irwig, L., Macaskill, P., d’Assuncao, J., Richards, A., Farnsworth, A. “Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study.” BMJ, 335(2007): 31–35.
  16. Department of Health. Cervical Screening Programme. London. Statistical Bulletin 24(2003), October 2003.
  17. Gupta, S., Halder, K., Khan, V.A., Sodhani, P. “Cell block as an adjunt to conventional Papanicolaou smear or diagnosis of cervical cancer in resource-limited settings.” Cytopathology, 18(2007): 309–315.
  18. Horn, L.C., Raptis, G., Nenning, H. “DNA Cytometric Analysis of Surgically Treated Squamous Cell Cancer of the Uterine Cervix, Stage pT1b1-pt2b.” Anal Quant Cytol Histol, 24(1) (2002): 23–29.
  19. Hutchinson, M.L., Isenstein, L.M., Goodman, A., Hurley, A.A., Douglass, K.L., Mui K.K., Patten, F.W., Zahniser, D.J. “Homogenous sampling accounts for the increased diagnostic accuracy using the ThinPrep Processor.” Am J Clin Pathol, 101(2) (1994): 215–219.
  20. Institute of Management and Adminstration. Diagnostic testing and technology report: anatomic pathology and cytology: continued growth driven by Pap testing. Washington. G2 Reports January 2007.
  21. Leiman, G. “Liquid-Based Cytology: Under Scrutiny Down-Under.” Diagn Cytopathology, 35(7) (2007): 379–380.
  22. Mao, C., Balasubramian, A., Yu, M., Kiviat, N., Ridder, R., Reichert, A., Herkert, M., von Knebel Doeberitz, M., Koutsky, L.A. “Evaluation of a new p16(INK4A) ELISA test and a high-risk HPV DNA test for cervical cancer screening: results from proof-ofconcept study.” Int J Cancer, 120(11) (2007): 2435–2438.
  23. Marquardt, K., Büttner, H.H., Broschewitz, U., Barten, M. “Die Restinzidenz des Zervixkarzinoms in Deutschland.” Frauenarzt, 45(2005): 812–815.
  24. McQueen, F., Duvall, E. “Using a quality control approach to define an «adequately cellular» liquid based cervical cytology specimen.” Cytopathology, 17(2006): 168–174.
  25. Mehes, G., Speich, N., Bollmann, M., Bollmann R. “Chromosomal Aberration Accumulate in Polyploid cells of High-grade Squamous Intraepithelial Lesions (HSIL).” Pathol Oncol Res, 10(3) (2004): 142–148.
  26. Moss, S., Gray, A., Legood, R., Henstock, E. Evaluation of HPV/LBC cervical screening pilot studies. First report to the Department of Health on evaluation of LBC. London. Department of Health (2002).
  27. Nanda, K., McCory, D.C., Myers, E.R., Bastian, L.A., Hasselblad, V., Hickey, J.D. “Accuracy of the Papanicolaou test in screening for and followup of cervical cytologic abrnormalities: a systematic review.” Ann Intern Med, 6(132)(10) (2000): 810–819.
  28. NHS CSP publication. External Quality Assessment Scheme for the Evaluation of Papanicolaou Staining in Cervical Cytology. London. Department of Health (2004).
  29. Obwegeser, J., Schneider, V. “Thin-layer cervical technology: A new meta-analysis.” Lancet, 367(2006): 88–89.
  30. Papanicolaou, G.N., Traut, H.F. Diagnosis of uterine cancer by the vaginal smear. New York. Commonwealth Fund (1943).
  31. Petry, K.U., Menton, S., Loenen-Frosch, F., de Carvalho, G.H., Holz, B., Schopp, B., Garbrecht-Buettner, S., Davies, P., Boehmer, G., van den Akker, E., Iftner, T. “Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients.” Br J Cancer, 88(2003): 1570–1577.
  32. Renshaw, A.A., Young, N.A., Birdsong, G.G., Styer, P.E., Davey, D.D., Mody, D.R., Colgan, T.J. “Comparison of performance of conventional ThinPrep gynecologic preparations in the College of American Pathologists Gynecologic Cytology Program.” Arch Pathol Lab Med, 128(2004): 17–22.
  33. Ronco, G., Segnan, N., Giorgi-Rossi, P., Zappa, M., Casadei, G.P., Carozzi, F., Palma, P.D., del Mistro, A., Folicaldi, S., Gillio-Tos, A., Nardo, G., Naldoni, C., Schincaglia, P., Zorzi, M., Confortini, M., Cuszick, J. “Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled Trial.” J Natl Cancer Inst, 98(2006): 765–774.
  34. Ronco, G., Cuzick, J., Pierotti, P., Cariaggi, M.P., dalla Palma, P., Naldoni, C., Ghiringhello, B., Giorgi-Rossi, P., Minucci, D., Parisio, F., Pojer, A., Schiboni, M.L., Sintoni, C., Zorzi, M., Segnan, N., Confortini, M. “Accuracy of liquid based cytology versus conventional cytology; overall results of the new technologies for cervical screening (NTCC) randomized controlled trial.” BMJ, 335(2007): 28–31.
  35. Ronco, G., Vineis, C., Montanari, G., Orlassino, R., Parisio, F., Arnaud, S., Berardengo, E., Fabbrini, T., Segnan, N. “Impact of the AutoPap (currently Focal Point) Primary Screening System Location Guide Use on Interpretation Time and Diagnostic.” Cancer, 99(2003): 83–88.
  36. Rosenthal, D.L., Geddes, S., Trimble, C.L., Carson, K.A., Alli, P.M. “The PapSpin: A Reasonable Alternative to Other, More Expensive Liquid-Based Papanicolaou Tests.” Cancer Cytopathology, 108(3) (2006): 137–143.
  37. Schenk, U., Schwarz, G. “Probleme der Praparationstechnik.” Micro Acta Suppl, 6(1983): 13–19.
  38. Schneider, A., Hoyer, H., Lotz, B., Leistritz, S., Kühne-Heid, R., Nindl, I., Müller, B., Haerting, J., Dürst, M. “Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy.” Int J Cancer, 89(2000): 529–534.
  39. Schneider, A., Meinhardt, G., de Villiers, E.M., Gissmann, L. “Sensitivity of the cytologic diagnosis of cervical condyloma in comparison with HPV DNA hybridization studies.” Diagn Cytopathol, 3(1987): 250–255.
  40. Schneider, A., Schwarz, T.F., Hammerschmidt, T., Rash, R.M., Siebert, U. “Vorgehen und Kosten bei der Abklarung und Behandlung unklarer und abnormaler zytologischer Befunde des Pap- Abstrichs im Rahmen der Krebsfruherkennungsuntersuchung en.” Geburtsh Frauenheilk, 67(2007): 859–865.
  41. Sheriff, S.K., Petry, K.U., Ikenberg, H., Crouse, G., Mazonson, P.D., Santas, C.C. “An economic analysis of human papillomavirus triage for the management of women with atypical and abnormal Pap smear results in Germany.” Eur J Health Econ, 8(2) (2007): 153–60. Epub Feb 17, 2007.
  42. Siebert, U., Muth, C., Sroczynski, G., Velasco-Garrido, M., Gerhardus, A., Gibis, B. Dunnschichtpraparationen und computergestutzte Untersuchungen von Zervixabstrichen im Rahmen der Krebsfruherkennung. Sankt Augustin. Asgard-Verlag (2003): 35.
  43. Sokolova, I., Algeciras-Schimnich, A., Song, M., Sitailo, S., Policht, F., Kipp, B.R., Voss, J.S., Halling, K.C., Ruth, A., King, W., Underwood, D., Brainard, J., Morrison, L. “Chromosomal biomarkers for detection of human papillomavirus associated genomic instability in epithelial cells of cervical cytology specimens.” J Mol Diagn, 9(5) (2007):604–611.
  44. Solomon, D., Nayar, R. The Bethesda System for Reporting Cervical Cytology. Definitions, Criteria and Explanatory Notes // 2nd ed. Heidelberg. Springer (2004).
  45. Tasca, L., Östör, A.G., Babes, V. “History of Gynecologic Pathology.” Int J Gynecol Pathol, 21(2002): 198–202.
  46. Varnai, A.D., Bollmann, M., Bankfalvi, A., Speich, N., Schmitt, C., Griefingholt, H., Kovács, K., Klozoris, C., Bollmann, R. “Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: Diagnostic and Prognostic implications.” Oncol Rep, 19(2) (2008): 457–465.
  47. Varnai, A.D., Bollmann, M., Bankfalvi, A., Griefingholt, H., Pfening, N., Schmitt, C., Pajor, L., Bollmann, R. “The spectrum of cervical diseases induced by low-risk and undefined-risk HPVS: implication for patient management.” Anticancer Res, 27(1B) (2007): 563–570.
  48. Wilbur, D., Prey, M., Miller, W., Pawlick, G., Colgan, T. “The AutoPap System for Primary Screening in Cervial Cytology. Comparing the Results of a Prospective, Intended-Use Study with Routine Manual Practice.” Acta Cytol, 42(1998): 214–220.
  49. Williams, A. “Liquid based cytology and conventional smears compared over two 12 month periods.” Cytopathology, 17(2006): 82–85.
  50. Yeoh, G.P.S., Chan, K.W. “Cell block preparation on residual ThinPrep sample.” Diagn Cytopathol, 21(1999): 427–31.
  51. Zhang, F.F., Banks, H.W., Langford, S.M., Davey, D.D. “Accuracy of ThinPrep Imaging System in Detecting Low-Grade Squamous Intraepithelial Lesions.” Arch Pathol Lab Med, 131(2007): 773–776.

Downloads

Published

2015-02-11

How to Cite

Bollmann, R. (2015). Liquid-based cytology for risk-adapted cervical screening. REPRODUCTIVE ENDOCRINOLOGY, (21), 95–101. https://doi.org/10.18370/2309-4117.2015.21.95-101

Issue

No. 21 (2015)

Section

Laboratory diagnosis

License

Copyright (c) 2015 Reinhard Bollmann

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.